{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,19]],"date-time":"2026-10-19T20:52:37Z","timestamp":1792443157239,"version":"4.5.0"},"reference-count":39,"publisher":"BMJ","issue":"6","license":[{"start":{"date-parts":[[2023,7,28]],"date-time":"2023-07-28T00:00:00Z","timestamp":1690502400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["Frontline Gastroenterol"],"published-print":{"date-parts":[[2023,11]]},"abstract":"<jats:p>The prevalence of cirrhosis has risen significantly over recent decades and is predicted to rise further. Widespread use of non-invasive testing means cirrhosis is increasingly diagnosed at an earlier stage. Despite this, there are significant variations in outcomes in patients with cirrhosis across the UK, and patients in areas with higher levels of deprivation are more likely to die from their liver disease. This three-part best practice guidance aims to address outpatient management of cirrhosis, in order to standardise care and to reduce the risk of progression, decompensation and mortality from liver disease. Here, in part one, we focus on outpatient management of compensated cirrhosis, encompassing hepatocellular cancer surveillance, screening for varices and osteoporosis, vaccination and lifestyle measures. We also introduce a compensated cirrhosis care bundle for use in the outpatient setting. Part two concentrates on outpatient management of decompensated disease including management of ascites, encephalopathy, varices, nutrition as well as liver transplantation and palliative care. The third part of the guidance covers special circumstances encountered in managing people with cirrhosis: surgery, pregnancy, travel, managing bleeding risk for invasive procedures and portal vein thrombosis.<\/jats:p>","DOI":"10.1136\/flgastro-2023-102430","type":"journal-article","created":{"date-parts":[[2023,7,28]],"date-time":"2023-07-28T13:23:53Z","timestamp":1690550633000},"page":"453-461","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":14,"title":["British Society of Gastroenterology Best Practice Guidance: outpatient management of cirrhosis \u2013 part 1: compensated cirrhosis"],"prefix":"10.1136","volume":"14","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8367-4232","authenticated-orcid":false,"given":"Dina","family":"Mansour","sequence":"first","affiliation":[{"name":"Newcastle Medical School, Newcastle University, Newcastle upon Tyne, UK"},{"name":"Gastroenterology and hepatology, Gateshead Health NHS Foundation Trust, Gateshead, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1041-9844","authenticated-orcid":false,"given":"Steven","family":"Masson","sequence":"additional","affiliation":[{"name":"Newcastle Medical School, Newcastle University, Newcastle upon Tyne, UK"},{"name":"Hepatology, Newcastle upon Tyne Hospitals NHS Foundation Trust, Newcastle, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Debbie L","family":"Shawcross","sequence":"additional","affiliation":[{"name":"Liver Unit, King's College Hospital, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7870-7984","authenticated-orcid":false,"given":"Andrew C","family":"Douds","sequence":"additional","affiliation":[{"name":"Gastroenterology, Queen Elizabeth Hospital, Kings Lynn, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emily","family":"Bonner","sequence":"additional","affiliation":[{"name":"Anaesthetics, Freeman Hospital, Newcastle upon Tyne, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lynsey","family":"Corless","sequence":"additional","affiliation":[{"name":"Gastroenterology, Hull Royal Infirmary, Hull, UK"},{"name":"Hull York Medical School, Hull, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9443-4552","authenticated-orcid":false,"given":"Joanna A","family":"Leithead","sequence":"additional","affiliation":[{"name":"Gastroenterology and Hepatology, Forth Valley Royal Hospital, Larbert, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John","family":"Hammond","sequence":"additional","affiliation":[{"name":"Hepatopancreatobiliary Multidisciplinary Team, Newcastle upon Tyne Hospitals NHS Foundation Trust, Freeman Hospital, Newcastle upon Tyne, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5441-9064","authenticated-orcid":false,"given":"Michael A","family":"Heneghan","sequence":"additional","affiliation":[{"name":"Institute of Liver Studies, King's College Hospital NHS Foundation Trust, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7733-8278","authenticated-orcid":false,"given":"Mussarat Nazia","family":"Rahim","sequence":"additional","affiliation":[{"name":"Institute of Liver Studies, King's College Hospital, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9043-6382","authenticated-orcid":false,"given":"Dhiraj","family":"Tripathi","sequence":"additional","affiliation":[{"name":"Liver Unit, University Hospitals Birmingham NHS Foundation Trust, Birmingham, UK"},{"name":"Institute of Immunology and Immunotherapy, University of Birmingham, Birmingham, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rebecca","family":"West","sequence":"additional","affiliation":[{"name":"British Liver Trust, Ringwood, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jill","family":"Johnson","sequence":"additional","affiliation":[{"name":"Dietetics, Queen Elizabeth Hospital Birmingham, Birmingham, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gemma","family":"Botterill","sequence":"additional","affiliation":[{"name":"Queen Elizabeth Hospital Birmingham, Birmingham, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Coral","family":"Hollywood","sequence":"additional","affiliation":[{"name":"Hepatology, Gloucestershire Hospitals NHS Foundation Trust, Cheltenham, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valerie","family":"Ross","sequence":"additional","affiliation":[{"name":"Pharmacy, Barts and The London NHS Trust, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mhairi","family":"Donnelly","sequence":"additional","affiliation":[{"name":"Hepatology, Royal Infirmary of Edinburgh, Edinburgh, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juliet E","family":"Compston","sequence":"additional","affiliation":[{"name":"Medicine, University of Cambridge School of Clinical Medicine, Cambridge, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5638-2453","authenticated-orcid":false,"given":"Stuart","family":"McPherson","sequence":"additional","affiliation":[{"name":"Newcastle Medical School, Newcastle University, Newcastle upon Tyne, UK"},{"name":"Hepatology, Newcastle upon Tyne Hospitals NHS Foundation Trust, Newcastle upon Tyne, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Allison","family":"Grapes","sequence":"additional","affiliation":[{"name":"Gastroenterology and hepatology, Gateshead Health NHS Foundation Trust, Gateshead, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2023,7,28]]},"reference":[{"key":"2025090708444643000_14.6.453.1","unstructured":"NOMIS official labour market Statistics: mortality statistics \u2013 underlying cause sex and age. Office for National Statistics; 2022."},{"key":"2025090708444643000_14.6.453.2","unstructured":"PHE . Liver disease profiles. 2021. Available: https:\/\/www.gov.uk\/government\/statistics\/liver-disease-profiles-november-2021-update\/liver-disease-profiles-november-2021-update"},{"key":"2025090708444643000_14.6.453.3","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2005.10.013"},{"key":"2025090708444643000_14.6.453.4","first-page":"1","article-title":"Surgery and portal hypertension","volume":"1","author":"Child","year":"1964","journal-title":"Major Probl Clin Surg"},{"key":"2025090708444643000_14.6.453.5","doi-asserted-by":"crossref","first-page":"1887","DOI":"10.1053\/j.gastro.2021.08.050","article-title":"MELD 3.0: the model for end-stage liver disease updated for the modern era","volume":"161","author":"Kim","year":"2021","journal-title":"Gastroenterology"},{"key":"2025090708444643000_14.6.453.6","doi-asserted-by":"publisher","DOI":"10.1136\/gut.2007.131730"},{"key":"2025090708444643000_14.6.453.7","unstructured":"Oates B . Gastroenteronterology GIRFT programme national speciality report; 2021."},{"key":"2025090708444643000_14.6.453.8","doi-asserted-by":"publisher","DOI":"10.1136\/flgastro-2016-100761"},{"key":"2025090708444643000_14.6.453.9","doi-asserted-by":"publisher","DOI":"10.1136\/gutjnl-2015-309262"},{"key":"2025090708444643000_14.6.453.10","unstructured":"NICE . Cirrhosis in over 16S: assessment and management: NICE guideline. NG50; 2016."},{"key":"2025090708444643000_14.6.453.11","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2015.05.022"},{"key":"2025090708444643000_14.6.453.12","doi-asserted-by":"crossref","first-page":"1597","DOI":"10.1016\/S0140-6736(18)31875-0","article-title":"\u0392 blockers to prevent decompensation of cirrhosis in patients with clinically significant portal hypertension (PREDESCI): a randomised, double-blind, placebo-controlled, multicentre trial","volume":"393","author":"Villanueva","year":"2019","journal-title":"Lancet"},{"key":"2025090708444643000_14.6.453.13","doi-asserted-by":"crossref","first-page":"1014","DOI":"10.1016\/j.jhep.2022.05.021","article-title":"Carvedilol reduces the risk of decompensation and mortality in patients with compensated cirrhosis in a competing-risk meta-analysis","volume":"77","author":"Villanueva","year":"2022","journal-title":"J Hepatol"},{"key":"2025090708444643000_14.6.453.14","doi-asserted-by":"crossref","DOI":"10.1136\/bmjgast-2019-000290","article-title":"Study protocol for a randomised controlled trial of carvedilol versus variceal band ligation in primary prevention of variceal bleeding in liver cirrhosis (CALIBRE trial)","volume":"6","author":"Tripathi","year":"2019","journal-title":"BMJ Open Gastroenterol"},{"key":"2025090708444643000_14.6.453.15","unstructured":"Available: https:\/\/clinicaltrials.gov\/ct2\/show\/NCT03776955"},{"key":"2025090708444643000_14.6.453.16","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1016\/j.jhep.2021.12.022","article-title":"Baveno VII - renewing consensus in portal hypertension","volume":"76","author":"de Franchis","year":"2022","journal-title":"J Hepatol"},{"key":"2025090708444643000_14.6.453.17","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1111\/cen.13762","article-title":"The association between liver cirrhosis and fracture risk: a systematic review and meta-analysis","volume":"89","author":"Liang","year":"2018","journal-title":"Clin Endocrinol (Oxf)"},{"key":"2025090708444643000_14.6.453.18","doi-asserted-by":"crossref","DOI":"10.1007\/s11657-022-01061-5","article-title":"UK clinical guideline for the prevention and treatment of osteoporosis","volume":"17","author":"Gregson","year":"2022","journal-title":"Arch Osteoporos"},{"key":"2025090708444643000_14.6.453.19","doi-asserted-by":"crossref","DOI":"10.1016\/j.jhepr.2021.100232","article-title":"Primary liver cancer in the UK: incidence, incidence-based mortality, and survival by subtype, sex, and nation","volume":"3","author":"Burton","year":"2021","journal-title":"JHEP Rep"},{"key":"2025090708444643000_14.6.453.20","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1038\/s41416-021-01509-4","article-title":"Regional variations in hepatocellular carcinoma incidence, routes to diagnosis, treatment and survival in England","volume":"126","author":"Burton","year":"2022","journal-title":"Br J Cancer"},{"key":"2025090708444643000_14.6.453.21","doi-asserted-by":"publisher","DOI":"10.1136\/flgastro-2015-100617"},{"key":"2025090708444643000_14.6.453.22","doi-asserted-by":"crossref","first-page":"s66","DOI":"10.7861\/clinmedicine.18-2-s66","article-title":"Surveillance for hepatocellular cancer","volume":"18","author":"Roskilly","year":"2018","journal-title":"Clin Med (Lond)"},{"key":"2025090708444643000_14.6.453.23","unstructured":"UKHSA . 2013. Available: https:\/\/www.gov.uk\/government\/collections\/immunisation-against-infectious-disease-the-green-book"},{"key":"2025090708444643000_14.6.453.24","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/j.jhep.2018.03.018","article-title":"EASL clinical practice guidelines: management of alcohol-related liver disease","volume":"69","author":"Thursz","year":"2018","journal-title":"J Hepatol"},{"key":"2025090708444643000_14.6.453.25","unstructured":"NICE . Alcohol-use disorders: diagnosis, assessment and management of harmful drinking (high-risk drinking) and alcohol dependence. NICE; 2011."},{"key":"2025090708444643000_14.6.453.26","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1002\/hep.30866","article-title":"Diagnosis and treatment of alcohol-associated liver diseases: 2019 practice guidance from the American Association for the study of liver diseases","volume":"71","author":"Crabb","year":"2020","journal-title":"Hepatology"},{"key":"2025090708444643000_14.6.453.27","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1016\/S2215-0366(18)30303-1","article-title":"Baclofen for the treatment of alcohol use disorder: the Cagliari statement","volume":"5","author":"Agabio","year":"2018","journal-title":"Lancet Psychiatry"},{"key":"2025090708444643000_14.6.453.28","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(07)61814-5"},{"key":"2025090708444643000_14.6.453.29","unstructured":"NIHR . An adaptive-design randomised placebo-controlled trial of baclofen in the treatment of alcohol use disorder in patients with liver cirrhosis (BASIS). 2022. Available: https:\/\/fundingawards.nihr.ac.uk\/award\/NIHR131129"},{"key":"2025090708444643000_14.6.453.30","unstructured":"NICE . Alcohol-use disorders: physical complications: evidence update March 2012, in a summary of selected new evidence relevant to NICE clinical guideline 100 'diagnosis and management of alcohol-related physical complications. London NICE; 2010."},{"key":"2025090708444643000_14.6.453.31","unstructured":"DVLA . 2022. Available: https:\/\/www.gov.uk\/guidance\/drug-or-alcohol-misuse-or-dependence-assessing-fitness-to-drive"},{"key":"2025090708444643000_14.6.453.32","doi-asserted-by":"publisher","DOI":"10.1016\/j.cgh.2011.08.016"},{"key":"2025090708444643000_14.6.453.33","doi-asserted-by":"publisher","DOI":"10.1097\/MEG.0b013e32834aa4bb"},{"key":"2025090708444643000_14.6.453.34","doi-asserted-by":"crossref","first-page":"1735","DOI":"10.1007\/s10620-015-4015-z","article-title":"The Royal free hospital-nutritional prioritizing tool is an independent predictor of deterioration of liver function and survival in cirrhosis","volume":"61","author":"Borhofen","year":"2016","journal-title":"Dig Dis Sci"},{"key":"2025090708444643000_14.6.453.35","unstructured":"UCSF . Available: https:\/\/liverfrailtyindex.ucsf.edu"},{"key":"2025090708444643000_14.6.453.36","doi-asserted-by":"crossref","first-page":"1044","DOI":"10.1002\/hep.29003","article-title":"A practical approach to nutritional screening and assessment in cirrhosis","volume":"65","author":"Tandon","year":"2017","journal-title":"Hepatology"},{"key":"2025090708444643000_14.6.453.37","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2018.06.024"},{"key":"2025090708444643000_14.6.453.38","doi-asserted-by":"publisher","DOI":"10.1002\/hep.24418"},{"key":"2025090708444643000_14.6.453.39","doi-asserted-by":"publisher","DOI":"10.1136\/flgastro-2020-101480"}],"container-title":["Frontline Gastroenterology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/flgastro-2023-102430","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,7]],"date-time":"2025-09-07T15:44:54Z","timestamp":1757259894000},"score":1,"resource":{"primary":{"URL":"https:\/\/fg.bmj.com\/lookup\/doi\/10.1136\/flgastro-2023-102430"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,7,28]]},"references-count":39,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2023,10,10]]},"published-print":{"date-parts":[[2023,11]]}},"alternative-id":["10.1136\/flgastro-2023-102430"],"URL":"https:\/\/doi.org\/10.1136\/flgastro-2023-102430","relation":{},"ISSN":["2041-4137","2041-4145"],"issn-type":[{"value":"2041-4137","type":"print"},{"value":"2041-4145","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,7,28]]}}}